MedTrace Logo

DNA Methylation Biomarkers for Cervical Cancer Screening

NCT02605941 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2015-11-17

No results posted yet for this study

Summary

The purpose of this prospective study is to evaluate whether DNA methylation can be applied in cervical cancer screening.

Conditions

Sponsors & Collaborators

  • Mackay Memorial Hospital

    collaborator OTHER

  • Li Shin Hospital

    collaborator OTHER

  • Chang Gung Memorial Hospital

    collaborator OTHER

  • iStat Biomedical CO., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yuh-cheng Yang, MD · Mackay Memorial Hospital

  • Shih-chu Ho, MD · Li Shin Hospital

  • Ting-Chang Chang, MD., MPH. · Chang Gung Memorial Hospital

  • Chih-Long Chang, MD, Ph.D. · Mackay Memorial Hospital

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2015-12-31
Completion
2016-08-31

Countries

  • Taiwan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02605941 on ClinicalTrials.gov